Supplementary Data from Prophylactic <i>In Vivo</i> Hematopoietic Stem Cell Gene Therapy with an Immune Checkpoint Inhibitor Reverses Tumor Growth in Syngeneic Mouse Tumor Models
Chang Li(Academy of Military Medical Sciences), André Lieber(University of Washington)
Cited by 0
Related Papers
Correction of Enzymatic and Lysosomal Storage Defects in Fabry Mice by Adenovirus-Mediated Gene Transfer
|Human Gene Therapy|1999|97
Enhanced replication of SARS-CoV-2 Omicron BA.2 in human forebrain and midbrain organoids
|Signal Transduction and Targeted Therapy|2022|29
HDAd6/35++ - A new helper-dependent adenovirus vector platform for in vivo transduction of hematopoietic stem cells
|Molecular Therapy — Methods & Clinical Development|2023|22
Promising alternatives of CD47 monoclonal antibody: an injectable degradable hydrogel loaded with PQ912 for postoperative immunotherapy effectively blocks CD47-SIRPα signal
|Theranostics|2022|15
Resolving the chromatin impact of mosaic variants with targeted Fiber-seq
|Genome Research|2024|9